People who are obese with asthma may carry a specific trait that causes them to have poorer asthma control than their slim counterparts, suggests a new research.
In the study, researchers from Quebec, Canada compared pulmonary function changes, methacholine challenge scores, sputum induction cell counts, symptom perceptions, BMI/waist circumference, and waist-to-hip ratio of 44 obese subjects with asthma with 44 non-obese subjects with asthma.
Obesity
Obesity is a condition where there is excess accumulation of body fat which poses a risk to the health of the individual. It can affect children and adults.
Advertisement
Compared with those who were not obese, those who were obese had poorer asthma control, as well as lower total lung capacity, expiratory reserve volume, functional residual capacity, and residual volume.
Blood serum C-reactive protein and fibrinogen levels also were higher in obese subjects than non-obese subjects.
Bronchial and systemic inflammatory characteristics and patterns of pulmonary function changes suggest that obese patients may have a different phenotype of asthma.
The study has been published in the August issue of the journal CHEST.
Source: ANI
SRM
Bronchial and systemic inflammatory characteristics and patterns of pulmonary function changes suggest that obese patients may have a different phenotype of asthma.
The study has been published in the August issue of the journal CHEST.
Source: ANI
SRM
Ideal Body Weight
Calculate the ideal body weight for adults easily with Medindia's Ideal Body Weight Calculator.
Advertisement
 AsthmaIt''s a lung condition characterized by inflammation of the bronchi and constriction of the airways that result in coughing, wheezing or breathlessness. Allergy and other airway irritants can trigger it | Advertisement
|
Asthma Management - Animation
Metered Dose Inhalers(MDI), which delivers medictions directly to the lungs, can be most effectively used in the treatment of asthma.
Advertisement
Recommended Readings
Latest Obesity News
Regular exercise in obese individuals lowers memory loss and cognitive impairment, preventing neurodegenerative disorders including dementia.
Clinicians should take into account patients' BMI and RA-FQ scores when devising treatment strategies for RA flares, suggest researchers.
Study reveals the importance of host glycosylation, particularly GlcNAc-6-O-sulfation on intestinal mucins, in safeguarding against obesity and gut inflammation.
Metabolically healthy obesity are obese people with no metabolic complications but are at higher risk of metabolic co-morbidities compared to normal people.
KDS2010 drug was found to regulate astrocytes in brain which enhances fat metabolism resulting in weight loss without the need for dietary restrictions.